Data Foundry

Drug recalls 2015

Propofol Injectable Emulsion — Class I drug recall D-0389-2015

Terminated recall by Hospira Inc., reported 2015-02-25, distributed nationwide. Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

Recall numberD-0389-2015
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2014-10-06
Classified2015-02-13
Reported by FDA2015-02-25
Terminated2016-12-15
DistributedNationwide (US)
Quantity2,500 vials
Reason classestemperature control
NDC00409-0010, 00409-0010-97, 00409-0010-98, 00409-0501, 00409-0501-97, 00409-0501-98, 00409-1511, 00409-1511-97, 00409-1511-98, 00409-4699, 00409-4699-24, 00409-4699-30, 00409-4699-33, 00409-4699-50, 00409-4699-53, 00409-4699-54, 00409-6010, 00409-6010-02, 00409-6010-25
Lot numbers33-750-DJ
Expiration dates2015-09-01

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Reason for recall

Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0389-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.